Breast Cancer Home > Pergeta
Were you looking for information about Perjeta? Pergeta is a common misspelling of Perjeta.
As a type of biologic therapy, Perjeta™ (pertuzumab) may help in the treatment of certain types of breast cancer. The drug is specifically approved for use in adults and must be used in combination with certain other medications.
Perjeta is given as an intravenous infusion that is administered by a healthcare provider every three weeks. Although most people tolerate the medicine well, side effects (such as fatigue, diarrhea, and nausea) may occur.
(Click Perjeta for more information on what this medication is used for, dosing guidelines, and what your healthcare provider needs to know before you start treatment. You can also click any of the links in the box to the right for specific information.)